XanthoGenyx

XanthoGenyx is a development-stage biopharmaceutical company that is differentiated from other firms by its novel technology platform, innovative products and business strategy. The Company's products exploit multiple mechanisms of action concurrently to preclude the emergence of resistance, while enhancing an immune response to emerging cancer cells, as a comprehensive host immune response to cancer. The XanthoGenyx team has executive management experience in establishing start-up operations in the biopharmaceutical industry. The Company's Principals have experience in all aspects of pharmaceutical development, with a proven track record and the skills and knowledge required to take a biopharmaceutical product from discovery to next-stage development.